Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Grupo de Estudio de Infecciones en Transplantados.
Recruitment status was  Recruiting
Merck Sharp & Dohme Corp.
Information provided by:
Grupo de Estudio de Infecciones en Transplantados Identifier:
First received: June 4, 2006
Last updated: April 12, 2007
Last verified: December 2006
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given
Fortun J, Muñoz P, Cisneros JM, et al. Antifungal prophylaxis with caspofungin in high-risk liver transplant recipients: a noncomparative, open-label prospective clinical trial. Clinical Microbiology & Infection 12 (suppl. 4): P684, 2006. [Abstract on an interim analysis performed on the first 15 patients enrolled in the study, presented as a poster at 2006 ECCMID meeting].